
Kurma Partners has invested in a €4m extension round for MedLumics, which specialises in ablation systems for the treatment of atrial fibrillation.

Kurma Partners has invested in a €4m extension round for MedLumics, which specialises in ablation systems for the treatment of atrial fibrillation.
Recent Comments